Please use this identifier to cite or link to this item:
https://doi.org/10.1159/000535375
Title: | The Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients with Geographic Atrophy (OMEGA) Study: Design and Baseline Characteristics – OMEGA Report 1 | Authors: | Scholl, Hendrik P.N. Ansari, Georg Schärer, Nils Camenzind Zuche, Hanna Gabrani, Chrysoula Anders, Philipp Pfau, Kristina Valmaggia, Philippe Giani, Andrea Esmaeelpour, Marieh Chingning Yamaguchi, Taffeta Prünte, Christian F. Maloca, Peter M. Schmetterer, Leopold Scholl, Hendrik P.N. Pfau, Maximilian |
Keywords: | Clinical trials Endpoints Natural history study Geographic atrophy Age-related macular degeneration |
Issue Date: | 28-Nov-2023 | Publisher: | S. Karger AG | Citation: | Scholl, Hendrik P.N., Ansari, Georg, Schärer, Nils, Camenzind Zuche, Hanna, Gabrani, Chrysoula, Anders, Philipp, Pfau, Kristina, Valmaggia, Philippe, Giani, Andrea, Esmaeelpour, Marieh, Chingning Yamaguchi, Taffeta, Prünte, Christian F., Maloca, Peter M., Schmetterer, Leopold, Scholl, Hendrik P.N., Pfau, Maximilian (2023-11-28). The Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients with Geographic Atrophy (OMEGA) Study: Design and Baseline Characteristics – OMEGA Report 1. Ophthalmic Research 66 (1). ScholarBank@NUS Repository. https://doi.org/10.1159/000535375 | Rights: | Attribution-NonCommercial 4.0 International | Abstract: | Introduction: The aim of this study was to describe the design and the participants’ baseline characteristics of a prospective natural history study of geographic atrophy (GA) secondary to age-related macular degeneration. Methods: The optical coherence tomography (OCT) and microperimetry biomarker evaluation in patients with GA (OMEGA) study was conducted at a tertiary referral center (ClinicalTrials.gov identifier: NCT05963646). Participants were followed for 12 months during 4 visits (baseline and follow-up exams at weeks 12, 24, and 48) with best-corrected Early Treatment of Diabetic Retinopathy Study visual acuity, low-luminance visual acuity (LLVA), and quick contrast sensitivity function testing. Further, participants underwent spectral-domain OCT, OCT angiography, fundus autofluorescence imaging, and mesopic microperimetry testing. Results: Thirty participants (median [IQR] age of 79 [77, 84] years) and 37 study eyes were included with a (median [IQR]) GA area of 1.40 mm2 (0.49, 5.24) at baseline. Out of 37 study eyes, six developed macular neovascularizations (16%). The study-eye best-corrected visual acuity was (median [IQR]) 0.18 logarithm of the minimum angle of resolution (logMAR) (0.06, 0.26), LLVA 0.66 logMAR (0.36, 0.88), and the microperimetry mean sensitivity 18.4 dB (9.21, 20.9). The highest correlation between square root GA area and a visual function test was evident for LLVA (R2 of 0.578), followed by area under the log contrast sensitivity function curve (0.519) and microperimetral retinal sensitivity (0.487). Conclusion: This report lays out the design and baseline characteristics of the OMEGA study, which aims to contribute to the understanding of the natural history of GA. The OMEGA study will provide estimates of the ability to detect change and retest reliability for a panel of structure and functional assessments. | Source Title: | Ophthalmic Research | URI: | https://scholarbank.nus.edu.sg/handle/10635/246782 | ISSN: | 0030-3747 1423-0259 |
DOI: | 10.1159/000535375 | Rights: | Attribution-NonCommercial 4.0 International |
Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
ORE535375.pdf | 701.52 kB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License